ResearcherUniversity of SzegedActive in the last 2 years

Boshra Yosef

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5092267724. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

TRPV6-Mediated Ca2+ Signaling in Pancreatic Ductal Adenocarcinoma: From Cellular Physiology to Therapeutic Opportunities. Co-author DOI 10.3390/cancers18101670 ↗
MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. Co-author DOI 10.1159/000541874 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Viktória Venglovecz · 2 shared papers, 2025–2026 · strength 0.85
- Paper TRPV6-Mediated Ca2+ Signaling in Pancreatic Ductal Adenocarcinoma: From Cellular Physiology to Therapeutic Opportunitie… DOI 10.3390/cancers18101670 ↗
- Paper MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. DOI 10.1159/000541874 ↗
Eleonóra Gál · 1 shared paper, 2025 · strength 0.22
- Paper MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. DOI 10.1159/000541874 ↗
Zoltán Veréb · 1 shared paper, 2025 · strength 0.22
- Paper MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. DOI 10.1159/000541874 ↗
László Czakó · 1 shared paper, 2025 · strength 0.22
- Paper MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. DOI 10.1159/000541874 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.